pcos and tirzepatide How May Help Manage Weight Gain Before you jump into Tirzepatide

Metabolic disorders such as insulin resistance involve complex interactions between: pancreatic hormone signaling glucose production tissue insulin response energy metabolism Through GLP-1 and GIP receptor activity, researchers are investigating how retatrutide may influence insulin-related pathways and glucose homeostasis

Glucagon-like peptide 1 (GLP-1) receptor agonists are a class of medications that stimulate insulin production and suppress glucagon secretion

[12] [13] GLP-1 is an incretin hormone naturally produced in the intestine in response to food intake

The reviews conclude that incretin weight loss is largely fat loss, with only a modest absolute decline in lean body mass and no consistent drop in strength when people eat enough protein and keep moving

The medication reaches steady-state levels within four to five weeks of weekly dosing, meaning your body maintains therapeutic concentrations regardless of the exact day or time you inject

In clinical trials, tirzepatide has generally produced more weight loss , likely because it engages a second incretin pathway